These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 12404703

  • 1. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.
    Oades RD, Klimke A, Henning U, Rao ML.
    Hum Psychopharmacol; 2002 Jan; 17(1):15-27. PubMed ID: 12404703
    [Abstract] [Full Text] [Related]

  • 2. Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment.
    Cai HL, Fang PF, Li HD, Zhang XH, Hu L, Yang W, Ye HS.
    Psychiatry Res; 2011 Jul 30; 188(2):197-202. PubMed ID: 21146875
    [Abstract] [Full Text] [Related]

  • 3. Atypical antipsychotics and the relevance of glutamate and serotonin.
    van der Heijden FM, Tuinier S, Fekkes D, Sijben AE, Kahn RS, Verhoeven WM.
    Eur Neuropsychopharmacol; 2004 May 30; 14(3):259-65. PubMed ID: 15056486
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Catecholamine and indoleamine metabolism in groups of patients with paranoid and simple forms of schizophrenia].
    Gamaleia NB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981 May 30; 81(5):700-8. PubMed ID: 6168149
    [Abstract] [Full Text] [Related]

  • 7. [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
    Schulz E, Remschmidt H, Fleischhaker C.
    Z Kinder Jugendpsychiatr; 1994 Dec 30; 22(4):285-98. PubMed ID: 7856324
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G, Butini S, Fattorusso C, Catalanotti B, Gemma S, Nacci V, Morelli E, Cagnotto A, Mereghetti I, Mennini T, Carli M, Minetti P, Di Cesare MA, Mastroianni D, Scafetta N, Galletti B, Stasi MA, Castorina M, Pacifici L, Vertechy M, Di Serio S, Ghirardi O, Tinti O, Carminati P.
    J Med Chem; 2004 Jan 01; 47(1):143-57. PubMed ID: 14695828
    [Abstract] [Full Text] [Related]

  • 11. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M, Avital A, Derevenski A, Berstein S, Sandbank S, Weizman A.
    Int Clin Psychopharmacol; 2007 Jul 01; 22(4):192-6. PubMed ID: 17519641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.
    Suzuki E, Kanba S, Koshikawa H, Nibuya M, Yagi G, Asai M.
    J Psychiatry Neurosci; 1996 May 01; 21(3):167-71. PubMed ID: 8935328
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
    Mitani H, Shirayama Y, Yamada T, Kawahara R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May 01; 30(3):531-4. PubMed ID: 16414168
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Levels of biogenic amines, their metabolites, and tyrosine hydroxylase activity in the human epileptic temporal cortex.
    Pintor M, Mefford IN, Hutter I, Pocotte SL, Wyler AR, Nadi NS.
    Synapse; 1990 May 01; 5(2):152-6. PubMed ID: 1968684
    [Abstract] [Full Text] [Related]

  • 20. Monoaminergic dysregulation in glutathione-deficient mice: possible relevance to schizophrenia?
    Jacobsen JP, Rodriguiz RM, Mørk A, Wetsel WC.
    Neuroscience; 2005 May 01; 132(4):1055-72. PubMed ID: 15857710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.